Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Short term Debt (2022 - 2025)

Coeptis Therapeutics Holdings (COEP) has 3 years of Short term Debt data on record, last reported at $635489.0 in Q1 2025.

  • For Q1 2025, Short term Debt changed N/A year-over-year to $635489.0; the TTM value through Mar 2025 reached $635489.0, changed N/A, while the annual FY2024 figure was $1.0 million, N/A changed from the prior year.
  • Short term Debt reached $635489.0 in Q1 2025 per COEP's latest filing, down from $1.0 million in the prior quarter.
  • Across five years, Short term Debt topped out at $1.0 million in Q4 2024 and bottomed at $333335.0 in Q3 2022.
  • Average Short term Debt over 3 years is $670102.7, with a median of $635489.0 recorded in 2025.